1.	Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000675520, NCCTG-N09C6, N09C6, NCT01156142
2.	A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-034, NCT01355926
3.	CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000727295, NCCTG-N11C5, N11C5, NCT01545687
4.	Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 603EUSA03, NCT00901732
5.	Phase II Trial Evaluating Elimination of Radiation Therapy Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 07-0142 / 201106342, NCT00593840
6.	Preoperative Treatment With Cetuximab and/or IMC-A12 Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2008-0342, NCT00957853
7.	Preoperative Soy Isoflavone Supplementation in the Prevention of Head and Neck Squamous Carcinoma Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 19 to 80 Sponsor: Other Protocol IDs: UMCC 2009.008, HUM%26957, NCT01028001
8.	A Trial of Boost Vaccinations of Pancreatic Tumor Cell Vaccine Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J09100, NA_00031401, NCT01088789
9.	Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Phase: Phase II Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: ENT0033, SU-08222011-8290, 22329, NCI-2011-03271, NCT01437449
10.	A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 21 and over Sponsor: NIDCR, Other Protocol IDs: J1247, 2P50DE019032, NA_00073880, NCT01697800
11.	Vaccine Therapy in Treating Patients With Head and Neck Cancer Phase: Phase I Type: Treatment Status: Active Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000515081, PCI-03-156, PCI-0507062, NCT00404339
12.	Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: HP-41372, UMGCC 0804, NCT00704041
13.	Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Cancer Patients Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RON-SCCI 08-003-1, NCT00728130
14.	MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer Phase: Phase I Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000654169, UPCC-808258, 808258, NCT00984074
15.	Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System Phase: Phase I Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CCCWFU 60209, NCT01059357
16.	A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CLJM716X2101, 2011-004865-33, NCT01598077
17.	Molecular Classification of Head and Neck Tumors Using cDNA Microarray Analysis to Detect Prognosis and Response to Therapy Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: 02-05-127E, NIH-R21-CA104402, NCT00200486
18.	Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 186-03, ETH136-03D, NCT00206752
19.	Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000581171, P30CA012197, CCCWFU-60307, NCT00601913
20.	A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery Phase: No phase specified Type: Health services research, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-03-080, NCT00627562
21.	Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EPROST-20070918, SCCC-2008006, NCT00843635
22.	Curcumin Biomarker Trial in Head and Neck Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 90 Sponsor: NCI, Other Protocol IDs: H08-081, 1R21CA137545-01A2, FWCC, NCT01160302
23.	Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 09206, NCI-2010-02169, NCT01254734
24.	Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: OSU-07061, NCI-2011-03122, NCT01473784
25.	Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ENT0032, SU-08102011-8266, 21777, NCT01576939